These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 16032644)

  • 1. Prolonged gastric emptying half-time and gastric hypomotility after drug overdose.
    Adams BK; Mann MD; Aboo A; Isaacs S; Evans A
    Am J Emerg Med; 2004 Nov; 22(7):548-54. PubMed ID: 15666259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of sorbitol on gastric emptying half-times and small intestinal transit after drug overdose.
    Adams BK; Mann MD; Aboo A; Isaacs S; Evans A
    Am J Emerg Med; 2006 Jan; 24(1):130-2. PubMed ID: 16338524
    [No Abstract]   [Full Text] [Related]  

  • 3. Central effects of pituitary adenylate cyclase activating polypeptide (PACAP) on gastric motility and emptying in rats.
    Ozawa M; Aono M; Moriga M
    Dig Dis Sci; 1999 Apr; 44(4):735-43. PubMed ID: 10219831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nifedipine on gastric emptying and gastrointestinal motility in man.
    Santander R; Mena I; Gramisu M; Valenzuela JE
    Dig Dis Sci; 1988 May; 33(5):535-9. PubMed ID: 3282847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finally, a paper documenting the delay.
    Breyer K; Halcomb SE; Bouchard NC; Hoffman RS; Dohrenwend P; Howland MA
    Am J Emerg Med; 2005 Jul; 23(4):579. PubMed ID: 16032644
    [No Abstract]   [Full Text] [Related]  

  • 6. Endogenous opioids, gastric motility, and gastric emptying.
    Dubois A
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):56B-61B. PubMed ID: 3038652
    [No Abstract]   [Full Text] [Related]  

  • 7. [In which diseases is the use of motility-active measures indicated?].
    Wienbeck M; Barnert J
    Z Gastroenterol Verh; 1990 Apr; 25():138-40. PubMed ID: 1694351
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pharmacology forum: motility agents and the gastrointestinal tract.
    McCallum RW
    Am J Med Sci; 1996 Jul; 312(1):19-26. PubMed ID: 8686725
    [No Abstract]   [Full Text] [Related]  

  • 9. Motility-modifying agents and management of disorders of gastrointestinal motility.
    Pandolfino JE; Howden CW; Kahrilas PJ
    Gastroenterology; 2000 Feb; 118(2 Suppl 1):S32-47. PubMed ID: 10868897
    [No Abstract]   [Full Text] [Related]  

  • 10. [Has erythromycin a therapeutic role in gastroenterology in 1994?].
    Chaussade S
    Gastroenterol Clin Biol; 1994; 18(11):917-9. PubMed ID: 7705577
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pro-kinetic agents. Developments and indications].
    Layer P
    Z Gastroenterol Verh; 1991 Mar; 26():157-8. PubMed ID: 1714133
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.